Parkinson's Disease: Methods and Protocols
The use of molecular technologies to study Parkinson's disease in the laboratory is beginning to have a major impact in clinical medicine. In Parkinson's Disease: Methods and Protocols, internationally recognized biomedical investigators describe in detail the major techniques employed in...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
2001
|
Schriftenreihe: | Methods in Molecular Medicine™
62 |
Schlagworte: | |
Online-Zugang: | UBR01 TUM01 URL des Erstveröffentlichers |
Zusammenfassung: | The use of molecular technologies to study Parkinson's disease in the laboratory is beginning to have a major impact in clinical medicine. In Parkinson's Disease: Methods and Protocols, internationally recognized biomedical investigators describe in detail the major techniques employed in molecular and cellular studies of Parkinson's disease and basal ganglia function, adding along the way considerable background information about the rationale and utility of these methods, as well as about fundamental issues in Parkinson's disease. Widely varied methods are covered, including genetic analyses, molecular pathogenetic investigations of dopaminergic neuronal degeneration, biochemical studies of nigrostriatal neural circuitry, and molecular therapies, such as gene therapy and neural stem cells. Comprehensive and timely, Parkinson's Disease: Methods and Protocols offers scientists and clinicians interested in Parkinson's and related neurodegenerative disorders the major cutting-edge methods-in a readily reproducible format-needed to effectively exploit the potential of cell and molecular biology for elucidating disease mechanisms and for speeding the emergence of novel and more effective therapeutics |
Beschreibung: | 1 Online-Ressource (XI, 317 p) |
ISBN: | 9781592591428 |
DOI: | 10.1385/1592591426 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV044951243 | ||
003 | DE-604 | ||
005 | 20180828 | ||
007 | cr|uuu---uuuuu | ||
008 | 180517s2001 |||| o||u| ||||||eng d | ||
020 | |a 9781592591428 |9 978-1-59259-142-8 | ||
024 | 7 | |a 10.1385/1592591426 |2 doi | |
035 | |a (ZDB-2-PRO)978-1-59259-142-8 | ||
035 | |a (OCoLC)1184328097 | ||
035 | |a (DE-599)BVBBV044951243 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-91 | ||
050 | 0 | |a RC382 | |
082 | 0 | |a 616.8 |2 23 | |
082 | 0 | |a 616.8/33 |2 21 | |
084 | |a YG 5511 |0 (DE-625)153506:12917 |2 rvk | ||
245 | 1 | 0 | |a Parkinson's Disease |b Methods and Protocols |c edited by M. Maral Mouradian |
264 | 1 | |a Totowa, NJ |b Humana Press |c 2001 | |
300 | |a 1 Online-Ressource (XI, 317 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Methods in Molecular Medicine™ |v 62 | |
520 | |a The use of molecular technologies to study Parkinson's disease in the laboratory is beginning to have a major impact in clinical medicine. In Parkinson's Disease: Methods and Protocols, internationally recognized biomedical investigators describe in detail the major techniques employed in molecular and cellular studies of Parkinson's disease and basal ganglia function, adding along the way considerable background information about the rationale and utility of these methods, as well as about fundamental issues in Parkinson's disease. Widely varied methods are covered, including genetic analyses, molecular pathogenetic investigations of dopaminergic neuronal degeneration, biochemical studies of nigrostriatal neural circuitry, and molecular therapies, such as gene therapy and neural stem cells. Comprehensive and timely, Parkinson's Disease: Methods and Protocols offers scientists and clinicians interested in Parkinson's and related neurodegenerative disorders the major cutting-edge methods-in a readily reproducible format-needed to effectively exploit the potential of cell and molecular biology for elucidating disease mechanisms and for speeding the emergence of novel and more effective therapeutics | ||
650 | 4 | |a Medicine & Public Health | |
650 | 4 | |a Neurology | |
650 | 4 | |a Medicine | |
650 | 4 | |a Neurology | |
650 | 0 | 7 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Molekulare Medizin |0 (DE-588)4543844-4 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |D s |
689 | 0 | 1 | |a Molekulare Medizin |0 (DE-588)4543844-4 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Maral Mouradian, M. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780896037618 |
856 | 4 | 0 | |u https://doi.org/10.1385/1592591426 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-PRO | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-030344001 | ||
966 | e | |u https://doi.org/10.1385/1592591426 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1385/1592591426 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804178539625316352 |
---|---|
any_adam_object | |
author2 | Maral Mouradian, M. |
author2_role | edt |
author2_variant | m m m mm mmm |
author_facet | Maral Mouradian, M. |
building | Verbundindex |
bvnumber | BV044951243 |
callnumber-first | R - Medicine |
callnumber-label | RC382 |
callnumber-raw | RC382 |
callnumber-search | RC382 |
callnumber-sort | RC 3382 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | YG 5511 |
collection | ZDB-2-PRO |
ctrlnum | (ZDB-2-PRO)978-1-59259-142-8 (OCoLC)1184328097 (DE-599)BVBBV044951243 |
dewey-full | 616.8 616.8/33 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.8 616.8/33 |
dewey-search | 616.8 616.8/33 |
dewey-sort | 3616.8 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1385/1592591426 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03009nmm a2200517zcb4500</leader><controlfield tag="001">BV044951243</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180828 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180517s2001 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781592591428</subfield><subfield code="9">978-1-59259-142-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1385/1592591426</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-59259-142-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1184328097</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044951243</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC382</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8</subfield><subfield code="2">23</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/33</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 5511</subfield><subfield code="0">(DE-625)153506:12917</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Parkinson's Disease</subfield><subfield code="b">Methods and Protocols</subfield><subfield code="c">edited by M. Maral Mouradian</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XI, 317 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Molecular Medicine™</subfield><subfield code="v">62</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The use of molecular technologies to study Parkinson's disease in the laboratory is beginning to have a major impact in clinical medicine. In Parkinson's Disease: Methods and Protocols, internationally recognized biomedical investigators describe in detail the major techniques employed in molecular and cellular studies of Parkinson's disease and basal ganglia function, adding along the way considerable background information about the rationale and utility of these methods, as well as about fundamental issues in Parkinson's disease. Widely varied methods are covered, including genetic analyses, molecular pathogenetic investigations of dopaminergic neuronal degeneration, biochemical studies of nigrostriatal neural circuitry, and molecular therapies, such as gene therapy and neural stem cells. Comprehensive and timely, Parkinson's Disease: Methods and Protocols offers scientists and clinicians interested in Parkinson's and related neurodegenerative disorders the major cutting-edge methods-in a readily reproducible format-needed to effectively exploit the potential of cell and molecular biology for elucidating disease mechanisms and for speeding the emergence of novel and more effective therapeutics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine & Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Molekulare Medizin</subfield><subfield code="0">(DE-588)4543844-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Molekulare Medizin</subfield><subfield code="0">(DE-588)4543844-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maral Mouradian, M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780896037618</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1385/1592591426</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030344001</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1385/1592591426</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1385/1592591426</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV044951243 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:05:35Z |
institution | BVB |
isbn | 9781592591428 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030344001 |
oclc_num | 1184328097 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (XI, 317 p) |
psigel | ZDB-2-PRO |
publishDate | 2001 |
publishDateSearch | 2001 |
publishDateSort | 2001 |
publisher | Humana Press |
record_format | marc |
series2 | Methods in Molecular Medicine™ |
spelling | Parkinson's Disease Methods and Protocols edited by M. Maral Mouradian Totowa, NJ Humana Press 2001 1 Online-Ressource (XI, 317 p) txt rdacontent c rdamedia cr rdacarrier Methods in Molecular Medicine™ 62 The use of molecular technologies to study Parkinson's disease in the laboratory is beginning to have a major impact in clinical medicine. In Parkinson's Disease: Methods and Protocols, internationally recognized biomedical investigators describe in detail the major techniques employed in molecular and cellular studies of Parkinson's disease and basal ganglia function, adding along the way considerable background information about the rationale and utility of these methods, as well as about fundamental issues in Parkinson's disease. Widely varied methods are covered, including genetic analyses, molecular pathogenetic investigations of dopaminergic neuronal degeneration, biochemical studies of nigrostriatal neural circuitry, and molecular therapies, such as gene therapy and neural stem cells. Comprehensive and timely, Parkinson's Disease: Methods and Protocols offers scientists and clinicians interested in Parkinson's and related neurodegenerative disorders the major cutting-edge methods-in a readily reproducible format-needed to effectively exploit the potential of cell and molecular biology for elucidating disease mechanisms and for speeding the emergence of novel and more effective therapeutics Medicine & Public Health Neurology Medicine Parkinson-Krankheit (DE-588)4044683-9 gnd rswk-swf Molekulare Medizin (DE-588)4543844-4 gnd rswk-swf Parkinson-Krankheit (DE-588)4044683-9 s Molekulare Medizin (DE-588)4543844-4 s DE-604 Maral Mouradian, M. edt Erscheint auch als Druck-Ausgabe 9780896037618 https://doi.org/10.1385/1592591426 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Parkinson's Disease Methods and Protocols Medicine & Public Health Neurology Medicine Parkinson-Krankheit (DE-588)4044683-9 gnd Molekulare Medizin (DE-588)4543844-4 gnd |
subject_GND | (DE-588)4044683-9 (DE-588)4543844-4 |
title | Parkinson's Disease Methods and Protocols |
title_auth | Parkinson's Disease Methods and Protocols |
title_exact_search | Parkinson's Disease Methods and Protocols |
title_full | Parkinson's Disease Methods and Protocols edited by M. Maral Mouradian |
title_fullStr | Parkinson's Disease Methods and Protocols edited by M. Maral Mouradian |
title_full_unstemmed | Parkinson's Disease Methods and Protocols edited by M. Maral Mouradian |
title_short | Parkinson's Disease |
title_sort | parkinson s disease methods and protocols |
title_sub | Methods and Protocols |
topic | Medicine & Public Health Neurology Medicine Parkinson-Krankheit (DE-588)4044683-9 gnd Molekulare Medizin (DE-588)4543844-4 gnd |
topic_facet | Medicine & Public Health Neurology Medicine Parkinson-Krankheit Molekulare Medizin |
url | https://doi.org/10.1385/1592591426 |
work_keys_str_mv | AT maralmouradianm parkinsonsdiseasemethodsandprotocols |